M.S. Nagendra, Director General at Zydus Pharmaceuticals Mexico, explains the company’s unique business model, combining both branded generics and highly innovative medicines, while showcasing the strategic relevance of the Mexican affiliate within the global strategy of the company.
Could you introduce yourself to our international readers as well as the key activities and operations of Zydus Pharmaceuticals in Mexico?
"The global strategy of Zydus is to have a solid footprint in every big market in the world and Mexico stands within such a vision."
